Since inflammation plays a key role in T-2 toxin-evoked intestinal mucosal barrier dysfunction in mice, the expressions of inflammatory cytokines such as IL-1β, IL-6, IL-10 and TNF-α were examined using qPCR to explore whether the BA pretreatment ameliorated T-2 toxin-induced intestinal inflammation. The gene discussed is IL1B; the disease is inflammation.